Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

CleanSpark (CLSK) Upsizes $1.15B Zero‑Coupon Convertible; Shares Dip as Funds Target Power, AI Data Centers & $460M Buyback (Nov. 11, 2025)

CleanSpark (CLSK) Upsizes $1.15B Zero‑Coupon Convertible; Shares Dip as Funds Target Power, AI Data Centers & $460M Buyback (Nov. 11, 2025)

CleanSpark, Inc. upsized and priced a private offering of $1.15 billion in 0% convertible senior notes due 2032. The terms set an initial conversion rate of 52.1832 shares per $1,000 of notes, equating to an initial conversion price of $19.16—a 27.5% premium to Monday’s close. The company may increase the offering by $150 million if initial purchasers exercise a 13‑day option. The deal is slated to close on Nov. 13, subject to customary conditions. Nasdaq
11 November 2025
··
Hesai Group (HSAI) Turns Profitable in Q3, Wins Exclusive Li Auto Lidar Deal, and Guides Stronger Q4 — Nov. 11, 2025

Hesai Group (HSAI) Turns Profitable in Q3, Wins Exclusive Li Auto Lidar Deal, and Guides Stronger Q4 — Nov. 11, 2025

Hesai Group delivered two headlines today: a return to profitability on record quarterly results and a fresh commercial win as the exclusive lidar supplier for Li Auto’s next‑generation assisted‑driving platform. Management also guided to double‑digit growth for Q4, underscoring momentum in both ADAS and robotics lidar shipments. Quiver Quantitative+2PR Newswire+2
11 November 2025
·
Quoin Pharmaceuticals (QNRX) Soars After Hitting 4%/5% Topical Rapamycin Targets; Clinical Batches This Quarter, Human Trials 1H 2026 [Nov. 11, 2025]

Quoin Pharmaceuticals (QNRX) Soars After Hitting 4%/5% Topical Rapamycin Targets; Clinical Batches This Quarter, Human Trials 1H 2026 [Nov. 11, 2025]

Quoin Pharmaceuticals, Ltd. announced that it has successfully achieved target loading concentrations for two topical rapamycin delivery technologies—4% in its lotion and 5% in a dermal patch. The company said it will start manufacturing clinical and stability batches this quarter and is planning clinical testing in the first half of 2026. Initial targets include MLM and VM, which currently lack any FDA‑approved treatments. GlobeNewswire
11 November 2025
···
Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance Corporation reported its first results since the Skydance–Paramount merger and the stock rallied after management laid out a bigger streaming-and-studios investment plan and raised its cost‑savings target. Shares were up ~5.5% today as CEO David Ellison emphasized a tech‑forward overhaul, a fatter content slate, and a sharper path to profitability. Reuters
11 November 2025
··
Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

Trading in Aspire Biopharma swung sharply. A pre‑market “health‑care movers” screen showed ASBP briefly up more than 30%, before regular‑session selling pulled shares lower on very heavy volume. Mid‑session, ASBP was down roughly 20–25% versus Monday’s close, with an exceptionally wide intraday range—characteristic of micro‑cap names facing near‑term listing and financing milestones. Benzinga
11 November 2025
·
Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava plc reported weaker‑than‑expected first‑quarter fiscal 2026 results before the U.S. market open today and cut its full‑year guidance. Shares fell sharply in early trading as investors digested a year‑over‑year revenue decline and softer outlook; the company also announced an expanded multi‑year partnership with Toyota Racing Development. Business Wire+3Business Wire+3MarketWatch+3
11 November 2025
··
ZenaTech (ZENA) Q3: Revenue Jumps 1,225% as Drone‑as‑a‑Service Scales — All the News Today (Nov. 11, 2025)

ZenaTech (ZENA) Q3: Revenue Jumps 1,225% as Drone‑as‑a‑Service Scales — All the News Today (Nov. 11, 2025)

ZenaTech, Inc. reported record third‑quarter results this morning, led by a surge in Drone‑as‑a‑Service revenue and continued expansion via acquisitions. Financial outlets picked up the release across the day, while filings show the company furnished unaudited nine‑month financials to the SEC. Here’s everything published today, Nov. 11, 2025, plus what it means for the stock and the drone services market. GlobeNewswire
11 November 2025
····
SoFi (SOFI) Becomes First U.S. National Bank to Offer In‑App Crypto Trading; Stock Jumps on Nov. 11, 2025

SoFi (SOFI) Becomes First U.S. National Bank to Offer In‑App Crypto Trading; Stock Jumps on Nov. 11, 2025

SoFi Technologies today unveiled SoFi Crypto, restoring in‑app crypto trading for its members after a two‑year pause. The phased rollout starts immediately and will expand over the coming weeks. Members can purchase crypto straight from their SoFi Checking or Savings balance and manage digital assets alongside banking, lending and investing in one app. Business Wire
11 November 2025
···
Turbo Energy (NASDAQ: TURB) pops on tokenized EaaS pilot with Taurus & Stellar; Spain proof‑of‑concept goes live — Nov. 11, 2025

Turbo Energy (NASDAQ: TURB) pops on tokenized EaaS pilot with Taurus & Stellar; Spain proof‑of‑concept goes live — Nov. 11, 2025

Turbo Energy, S.A. unveiled a blockchain-based pilot to tokenize financing for hybrid solar‑plus‑storage projects, partnering with Switzerland’s Taurus and the Stellar Development Foundation. The initiative starts with a proof of concept at a Spanish supermarket and could become a new way to fund on‑site, battery‑integrated PPAs using Turbo’s SUNBOX systems. Shares whipsawed on the headline. GlobeNewswire
11 November 2025
·
enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026

enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026

enGene Holdings Inc. reported fresh preliminary data this morning from the pivotal cohort of its Phase 2 LEGEND trial of detalimogene voraplasmid in high‑risk, BCG‑unresponsive non‑muscle invasive bladder cancer with CIS. The readout shows a 62% complete response at 6 months, 56% at 3 months and 63% CR at any time under the trial’s amended protocol—plus a favorable safety profile. The company completed enrollment of 125 patients in the pivotal cohort, above target, and will refine its analysis with FDA input on the statistical analysis plan. Business Wire
11 November 2025
···
Enphase Energy (ENPH) News Today — Nov. 11, 2025: CEO Buys More Shares, Fresh Institutional Stakes Emerge, and EV Charger 2 Shipments Start Next Week

Enphase Energy (ENPH) News Today — Nov. 11, 2025: CEO Buys More Shares, Fresh Institutional Stakes Emerge, and EV Charger 2 Shipments Start Next Week

Enphase Energy, Inc. is back in focus today after a fresh insider purchase by President & CEO Badri Kothandaraman and newly filed fund positions crossed the wire. With shipments of the IQ® EV Charger 2 slated to kick off next week and regional battery incentives opening up in Southern California, investors have several near‑term catalysts to track—against the backdrop of tariff and policy headwinds flagged late last month. Enphase Investor+4SEC+4MarketBeat+4
11 November 2025
··
Beachbody (BODI) Jumps After First GAAP Profit; Canaccord Lifts Price Target to $9 — What Investors Need to Know Today (Nov. 11, 2025)

Beachbody (BODI) Jumps After First GAAP Profit; Canaccord Lifts Price Target to $9 — What Investors Need to Know Today (Nov. 11, 2025)

The Beachbody Company, Inc. is back in the headlines one day after reporting its first GAAP net profit since going public in 2021. Shares were among the morning’s biggest pre‑market movers and an analyst at Canaccord Genuity boosted the stock’s price target to $9, citing improving profitability trends. StreetInsider.com+3Business Wire+3
11 November 2025
·
XPeng (XPEV) Soars Up to 18% on Humanoid ‘IRON’ Robot and Robotaxi Momentum; Q3 Earnings Set for Nov. 17

XPeng (XPEV) Soars Up to 18% on Humanoid ‘IRON’ Robot and Robotaxi Momentum; Q3 Earnings Set for Nov. 17

November 11, 2025 — XPeng Inc. ripped higher today as enthusiasm around the company’s humanoid robot IRON and a fast‑developing robotaxi program spilled over from last week’s AI Day into markets. Hong Kong–listed shares jumped as much as ~18% intraday, while U.S. ADRs traded sharply higher, marking XPeng’s biggest one‑day pop in over two years, according to multiple market reports. Yahoo Finance
11 November 2025
····
1 … 56 57 58 59 60 … 164

Stock Market Today

  • DroneShield (ASX:DRO) slips 7.7% following disclosure of securities lending-linked stake by 5.15% holder
    July 25, 2026, 7:16 PM EDT. Shares of DroneShield (ASX:DRO) fell 7.7% to A$2.04 on volume of 10.1 million. JPMorgan reported holding a 5.15% stake (47.6 million shares), with 83.3% connected to securities lending arrangements. The company's market capitalisation is A$1.89 billion, representing about 7.7x expected FY2025 revenue (A$216.5 million). First-quarter revenue surged 121% to A$74.1 million; cash stood at A$222.8 million, with no debt. The CEO noted increased U.S. demand after the June award.